Sweden’s first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals

BACKGROUND: Opioid overdoses are a growing concern, particularly among people who inject drugs. Sweden, with a comparatively high proportion of drug-related mortality, introduced its first Take-Home Naloxone (THN) program in 2018, at the Stockholm needle and syringe program (NSP). In this study we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmén, Elin, Warnqvist, Anna, Kåberg, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121425/
https://www.ncbi.nlm.nih.gov/pubmed/37087485
http://dx.doi.org/10.1186/s13011-023-00533-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121425/
https://www.ncbi.nlm.nih.gov/pubmed/37087485
http://dx.doi.org/10.1186/s13011-023-00533-2

Ejemplares similares